Zhongyue Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhongyue Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Chao Tu
Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, China
1 shared publication - Lin Mei
Department of Orthopedics The Second Xiangya Hospital of Central South University Changsha Hunan China
1 shared publication Ruiling Xu
Department of Orthopaedics, The Second XiangYa Hospital, Central South University, Changsha, China
1 shared publication- Ruiqi Chen
Department of Orthopedics The Second Xiangya Hospital of Central South University Changsha Hunan China
1 shared publication - Xiaofeng Gong
Nanchang University 1 The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Institute of Organoid Research, School of Basic Medical Sciences, Institute of Biomedical Innovation, The First Affiliated Hospital, Jiangxi Medical College Nanchang, China
1 shared publication - Xiaolei Ren
Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China
1 shared publication
Latest Publications
- 4 October 2023
- Published by Springer Nature in Phenomics
- Vol. 4 (2) , 171-186
3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine
Sarcoma is a complex and heterogeneous cancer that has been difficult to study in vitro. While two-dimensional (2D) cell cultures and mouse models have been the dominant research tools, three-dimensional (3D) culture systems such as organoids have emerged as promising alternatives. In this review, we discuss recent developments in sarcoma organoid culture, with a focus on their potential as tools for drug screening and biobanking. We also highlight the ways in which sarcoma organoids have been used to investigate the mechanisms of gene regulation, drug resistance, metastasis, and immune interactions. Sarcoma organoids have shown to retain characteristics of in vivo biology within an in vitro system, making them a more representative model for sarcoma research. Our review suggests that sarcoma organoids offer a potential path forward for translational research in this field and may provide a platform for developing personalized therapies for sarcoma patients.
- 4 October 2023
- Published by Springer Nature in Phenomics
- Vol. 4 (2) , 171-186
3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine
Sarcoma is a complex and heterogeneous cancer that has been difficult to study in vitro. While two-dimensional (2D) cell cultures and mouse models have been the dominant research tools, three-dimensional (3D) culture systems such as organoids have emerged as promising alternatives. In this review, we discuss recent developments in sarcoma organoid culture, with a focus on their potential as tools for drug screening and biobanking. We also highlight the ways in which sarcoma organoids have been used to investigate the mechanisms of gene regulation, drug resistance, metastasis, and immune interactions. Sarcoma organoids have shown to retain characteristics of in vivo biology within an in vitro system, making them a more representative model for sarcoma research. Our review suggests that sarcoma organoids offer a potential path forward for translational research in this field and may provide a platform for developing personalized therapies for sarcoma patients.